PubMed

IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: implications for diabetic nephropathy.

Lupia E, Elliot SJ, Lenz O, Zheng F, Hattori M, Striker GE, Striker LJ.

Diabetes. 1999 Aug;48(8):1638-44.PMID: 10426384 [PubMed - indexed for MEDLINE]Related articlesFree article

Autocrine activation of the IGF-I signaling pathway in mesangial cells isolated from diabetic NOD mice.

Tack I, Elliot SJ, Potier M, Rivera A, Striker GE, Striker LJ.

Diabetes. 2002 Jan;51(1):182-8.PMID: 11756339 [PubMed - indexed for MEDLINE]Related articlesFree article

Mesangial cells from transgenic mice with progressive glomerulosclerosis exhibit stable, phenotypic changes including undetectable MMP-9 and increased type IV collagen.

Jacot TA, Striker GE, Stetler-Stevenson M, Striker LJ.

Lab Invest. 1996 Dec;75(6):791-9.PMID: 8973474 [PubMed - indexed for MEDLINE]Related articles

Increased expression of extracellular matrix proteins and decreased expression of matrix proteases after serial passage of glomerular mesangial cells.

Schnaper HW, Kopp JB, Poncelet AC, Hubchak SC, Stetler-Stevenson WG, Klotman PE, Kleinman HK.

J Cell Sci. 1996 Oct;109 ( Pt 10):2521-8.PMID: 8923213 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of matrix glycation on expression of type IV collagen, MMP-2, MMP-9 and TIMP-1 by human mesangial cells.

Anderson SS, Wu K, Nagase H, Stettler-Stevenson WG, Kim Y, Tsilibary EC.

Cell Adhes Commun. 1996 Aug;4(2):89-101.PMID: 8937745 [PubMed - indexed for MEDLINE]Related articles

Autocrine activation of the local insulin-like growth factor I system is up-regulated by estrogen receptor (ER)-independent estrogen actions and accounts for decreased ER expression in type 2 diabetic mesangial cells.

Karl M, Potier M, Schulman IH, Rivera A, Werner H, Fornoni A, Elliot SJ.

Endocrinology. 2005 Feb;146(2):889-900. Epub 2004 Nov 18.PMID: 15550505 [PubMed - indexed for MEDLINE]Related articlesFree article

Induction of nodular sclerosis by insulin in rat mesangial cells in vitro: studies of collagen.

Abrass CK, Spicer D, Raugi GJ.

Kidney Int. 1995 Jan;47(1):25-37.PMID: 7731154 [PubMed - indexed for MEDLINE]Related articles

High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1.

Singh R, Song RH, Alavi N, Pegoraro AA, Singh AK, Leehey DJ.

Exp Nephrol. 2001;9(4):249-57.PMID: 11423724 [PubMed - indexed for MEDLINE]Related articles

Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy.

McLennan SV, Wang XY, Moreno V, Yue DK, Twigg SM.

Endocrinology. 2004 Dec;145(12):5646-55. Epub 2004 Sep 2.PMID: 15345671 [PubMed - indexed for MEDLINE]Related articlesFree article

Thrombin stimulates synthesis of type IV collagen and tissue inhibitor of metalloproteinases-1 by cultured human mesangial cells.

Kaizuka M, Yamabe H, Osawa H, Okumura K, Fujimoto N.

J Am Soc Nephrol. 1999 Jul;10(7):1516-23.PMID: 10405207 [PubMed - indexed for MEDLINE]Related articlesFree article

Excessive synthesis of matrix metalloproteinases in exocrine tissues of NOD mouse models for Sjögren's syndrome.

Yamachika S, Nanni JM, Nguyen KH, Garces L, Lowry JM, Robinson CP, Brayer J, Oxford GE, da Silveira A, Kerr M, Peck AB, Humphreys-Beher MG.

J Rheumatol. 1998 Dec;25(12):2371-80.PMID: 9858432 [PubMed - indexed for MEDLINE]Related articles

Mesangial cells from diabetic NOD mice constitutively secrete increased amounts of insulin-like growth factor-I.

Elliot SJ, Striker LJ, Hattori M, Yang CW, He CJ, Peten EP, Striker GE.

Endocrinology. 1993 Oct;133(4):1783-8.PMID: 7691581 [PubMed - indexed for MEDLINE]Related articles

Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.

Okada M, Takemura T, Yanagida H, Yoshioka K.

Kidney Int. 2002 Jan;61(1):113-24.PMID: 11786091 [PubMed - indexed for MEDLINE]Related articlesFree article

Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis.

Riser BL, Denichilo M, Cortes P, Baker C, Grondin JM, Yee J, Narins RG.

J Am Soc Nephrol. 2000 Jan;11(1):25-38.PMID: 10616837 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of mesangium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy.

McLennan SV, Martell SK, Yue DK.

Diabetes. 2002 Aug;51(8):2612-8.PMID: 12145178 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin-like growth factor-1 stimulates production of mesangial cell matrix components.

Schreiber BD, Hughes ML, Groggel GC.

Clin Nephrol. 1995 Jun;43(6):368-74.PMID: 7554520 [PubMed - indexed for MEDLINE]Related articles

Pentosan polysulfate decreases proliferation and net extracellular matrix production in mouse mesangial cells.

Elliot SJ, Striker LJ, Stetler-Stevenson WG, Jacot TA, Striker GE.

J Am Soc Nephrol. 1999 Jan;10(1):62-8.PMID: 9890310 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of glucose and heparin on mesangial alpha 1(IV)COLL and MMP-2/TIMP-2 mRNA expression.

Caenazzo C, Garbisa S, Onisto M, Zampieri M, Baggio B, Gambaro G.

Nephrol Dial Transplant. 1997 Mar;12(3):443-8.PMID: 9075122 [PubMed - indexed for MEDLINE]Related articlesFree article

Overexpression of transforming growth factor-beta 1 mRNA is associated with up-regulation of glomerular tenascin and laminin gene expression in nonobese diabetic mice.

Yang CW, Hattori M, Vlassara H, He CJ, Carome MA, Yamato E, Elliot S, Striker GE, Striker LJ.

J Am Soc Nephrol. 1995 Feb;5(8):1610-7.PMID: 7538809 [PubMed - indexed for MEDLINE]Related articlesFree article

Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion.

Tomita M, Koike H, Han GD, Shimizu F, Kawachi H.

Clin Exp Nephrol. 2004 Mar;8(1):17-26.PMID: 15067512 [PubMed - indexed for MEDLINE]Related articles